AST 2014 - Cutting Edge of Transplantation


SA02d - Targeting Fibrosis Clinically: Can We Extend Results in Liver to Solid Organ Transplantation?


Feb 15, 2014 12:00pm ‐ Feb 15, 2014 12:30pm

Description

Fibrosis in the liver may be under the control of mechanisms not seen in the kidney. What is the evidence that targeting fibrosis has a role in liver injury and function?

Speaker(s):

  • Scott Friedman, MD, Professor and Chief of Liver Diseases, Icahn School of Medicine at Mount Sinai

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content